Hims & Hers Health Inc (NYSE:HIMS)’s traded shares stood at 24.17 million during the last session, with the company’s beta value hitting 2.07. At the close of trading, the stock’s price was $47.46, to imply a decrease of -1.04% or -$0.5 in intraday trading. The HIMS share’s 52-week high remains $72.98, putting it -53.77% down since that peak but still an impressive 71.62% since price per share fell to its 52-week low of $13.47. The company has a valuation of $10.62B, with an average of 63.24 million shares in intraday trading volume over the past 10 days and average of 45.67 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Hims & Hers Health Inc (HIMS), translating to a mean rating of 2.73. Of 13 analyst(s) looking at the stock, 0 analyst(s) give HIMS a Sell rating. 1 of those analysts rate the stock as Overweight while 5 advise Hold as 7 recommend it as a Buy.
Hims & Hers Health Inc (NYSE:HIMS) trade information
After registering a -1.04% downside in the last session, Hims & Hers Health Inc (HIMS) has traded red over the past five days. The 5-day price performance for the stock is 14.61%, and -16.40% over 30 days. With these gigs, the year-to-date price performance is 135.07%. Short interest in Hims & Hers Health Inc (NYSE:HIMS) saw shorts transact 61.69 million shares and set a 1.47 days time to cover.
The extremes give us $30 and $68 for target low and target high price respectively. As such, HIMS has been trading -43.28% off suggested target high and 36.79% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 17.22% for the past 5-year period. While 2025 is set for a 27.49% return in earnings, projections for the next 5 years are at 34.58% annually.
HIMS Dividends
Hims & Hers Health Inc has its next earnings report out on 2025-May-05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Hims & Hers Health Inc insiders hold 11.13% of total outstanding shares, with institutional holders owning 74.54% of the shares at 83.88% float percentage. In total, 74.54% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 16.47 million shares (or 7.6746% of shares), all amounting to roughly $332.55 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 14.57 million shares, or about 6.7907% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $294.25 million.
We also have iShares Trust-iShares Core S&P Mid-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Hims & Hers Health Inc (HIMS) shares. Going by data provided on May 31, 2025 , iShares Trust-iShares Core S&P Mid-Cap ETF holds roughly 6.21 shares. This is just over 2.88% of the total shares, with a market valuation of $294.65 million. Data from the same date shows that the other fund manager holds a little less at 5.47, or 2.54% of the shares, all valued at about 259.4 million.
